🇺🇸 FDA
Pipeline program

AUTO4

AUTO4-TL1

Phase 2 mab terminated

Quick answer

AUTO4 for T Cell Non-Hodgkin Lymphoma is a Phase 2 program (mab) at Autolus Therapeutics plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Autolus Therapeutics plc
Indication
T Cell Non-Hodgkin Lymphoma
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials